Cimetidine-induced remission of mycosis fungoides

EEG neurofeedback research: A fertile ground for psychiatry?

L'Encephale·2019

Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.

Leukemia·2016

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

Leukemia·2016

Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.

Leukemia & lymphoma·2016

Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study.

Leukemia & lymphoma·2016

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.

Leukemia·2015

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

Blood cancer journal·2026

Relapse and disability across the disease course of MOGAD: a real-world cohort study from northern China.

Multiple sclerosis and related disorders·2026

Recurrent giant retroperitoneal liposarcoma: A case report.

Medicine·2026

Nationwide Surveillance and Control Measures during Large Measles Outbreak, Bangladesh, 2026.

Emerging infectious diseases·2026

Candida lusitaniae as an Unusual Cause of Otomycosis: A Case Report and Literature Review.

Cureus·2026

Spectrometric Assessment of Intralot and Interlot Variability in Mycophenolate Mofetil for Injection Using Near-Infrared Spectrometry and Nonparametric Subcluster Detection.

Contact in context·2026

Related Experiment Videos

Cimetidine-induced remission of mycosis fungoides

Related Concept Videos

EEG neurofeedback research: A fertile ground for psychiatry?

Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.

Interferon in the Treatment of Refractory Multiple Myeloma: An Eastern Cooperative Oncology Group Study.

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

Relapse and disability across the disease course of MOGAD: a real-world cohort study from northern China.

Recurrent giant retroperitoneal liposarcoma: A case report.

Nationwide Surveillance and Control Measures during Large Measles Outbreak, Bangladesh, 2026.

Candida lusitaniae as an Unusual Cause of Otomycosis: A Case Report and Literature Review.

Spectrometric Assessment of Intralot and Interlot Variability in Mycophenolate Mofetil for Injection Using Near-Infrared Spectrometry and Nonparametric Subcluster Detection.

Related Experiment Videos

Cimetidine-induced remission of mycosis fungoides

Related Concept Videos

Related Articles